Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemorrhagic Risk Conditions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Not applicableLooking for participantsNCT07411079
What this trial is testing

Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

Who this might be right for
Intracerebral HemorrhageHemorrhagic Risk ConditionsBleeding Disorders
University Hospital, Lille 1,126
Early research (Phase 1)WithdrawnNCT00521261
What this trial is testing

Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT03421184
What this trial is testing

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus

Who this might be right for
Lupus ErythematosusRheumatoid ArthritisAutoimmune Thrombocytopenia
University Hospital, Bordeaux 63
Not applicableUnknownNCT01303900
What this trial is testing

Cardiovascular Disease (CVD) in Haemophilia

Who this might be right for
HaemophiliaCardiovascular Disease
UMC Utrecht 750
Not applicableActive Not RecruitingNCT05844033
What this trial is testing

Biomarker for Infection Risk in CLL and MM

Who this might be right for
Multiple MyelomaChronic Lymphocytic Leukemia
Massachusetts General Hospital 150
Testing effectiveness (Phase 2)Study completedNCT04731844
What this trial is testing

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Who this might be right for
Prostate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)+1 more
University of Rochester 30
Early research (Phase 1)Looking for participantsNCT04323748
What this trial is testing

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Who this might be right for
Immune Thrombocytopenic Purpura
New York Medical College 20
Early research (Phase 1)Ended earlyNCT00725062
What this trial is testing

Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00397813
What this trial is testing

Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

Who this might be right for
Atypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+11 more
Fred Hutchinson Cancer Center 77
Not applicableStudy completedNCT06784284
What this trial is testing

PREhospital Prediction of the Risk of Intracranial Hemorrhagic Injury in the Elderly Patient With a Fall

Who this might be right for
Intracranial HemorrhagesHead Trauma
University Hospital, Toulouse 1,100
Testing effectiveness (Phase 2)WithdrawnNCT05393999
What this trial is testing

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations

Who this might be right for
SARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory DiseaseMyeloma+4 more
Imperial College Healthcare NHS Trust
Testing effectiveness (Phase 2)Looking for participantsNCT03314974
What this trial is testing

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+25 more
Masonic Cancer Center, University of Minnesota 300
Not applicableStudy completedNCT07132996
What this trial is testing

Spleen Volume Change Predicts 45-Day Mortality in Neurocritical Care: A Prospective Cohort Study

Who this might be right for
Intracerebral Hemorrhage (ICH)Hemorrhagic Stroke, IntracerebralNeurocritical Care+2 more
Ankara City Hospital Bilkent 42
Not applicableStudy completedNCT01779635
What this trial is testing

Efficacy and Safety of Heparin-grafted Membrane for CRRT

Who this might be right for
Acute Kidney InjuryHemorrhageCoagulopathy
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)Study completedNCT01760655
What this trial is testing

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With Gene MutationsAcute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM+18 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Large-scale testing (Phase 3)Looking for participantsNCT07288489
What this trial is testing

Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.

Who this might be right for
Blood Loss, SurgicalCoagulation Disorder
VarmX B.V. 800
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Next Page